Gujarat inject (Kerala) Limited has announced securing a substantial purchase order worth ₹6.067 crores from Earthwave Technology Private Limited for solar photovoltaic modules. The company disclosed this significant business development through a regulatory filing under SEBI Regulation 30 compliance requirements.

Order Details and Specifications

The purchase order covers 7,041 units of Solar PV Module GS12R-T132-GF-620WP, with the total contract value of ₹6.067 crores being exclusive of GST. The modules are to be arranged and delivered to required sites as per the contract terms.

Contract Terms and Execution

The agreement represents a domestic transaction with Earthwave Technology Private Limited, with execution scheduled for completion by March 2026. The contract requires Gujarat Inject to arrange modules at required sites as specified in the order terms.

Regulatory Compliance and Disclosures

In compliance with SEBI regulations, the company confirmed that the promoter group has no interest in the contracting entity. The transaction does not fall under related party transactions, ensuring arm's length dealing principles.

The announcement was made through proper regulatory channels, with the company's Whole Time Director Murli Shivshankaran Nair signing the disclosure document dated March 16, 2026.

Source: None/Company/INE659F01014/c90357fb-0787-46a6-82d7-e48bb82232aa.pdf

Gujarat inject Kerala Limited has announced its unaudited standalone financial results for the third quarter and nine months ended December 31, 2025. The Board of Directors approved these results during their meeting held on February 14, 2026, under Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Board Meeting and Regulatory Compliance

The Board meeting was conducted on Saturday, February 14, 2026, commencing at 3:00 PM and concluding at 3:35 PM. The meeting was held pursuant to Regulation 30 of the SEBI Listing Regulations, where directors approved the unaudited financial results and took on record the Limited Review Report issued by M/s. S. Mandawat & Co., the company's statutory auditors.

Financial Performance Overview

The company's quarterly and nine-month financial performance demonstrates significant revenue growth compared to the previous year, though with varying profit margins across different reporting periods.

Quarterly Results Analysis

For the third quarter ended December 31, 2025, Gujarat Inject Kerala Limited reported revenue from operations of ₹162.51 lakh, marking a substantial increase from ₹13.80 lakh in the corresponding quarter of the previous year. However, the net profit for the quarter decreased to ₹3.80 lakh compared to ₹6.75 lakh in Q3FY25. The company's total expenses for Q3FY26 stood at ₹171.32 lakh, while the profit before tax was ₹5.08 lakh with current tax expense of ₹1.28 lakh.

Nine-Month Performance

For the nine months ended December 31, 2025, the company achieved revenue from operations of ₹502.26 lakh, significantly higher than ₹19.64 lakh in the corresponding period of the previous year. Net profit for the nine-month period was ₹94.40 lakh compared to ₹101.72 lakh in the previous year.

Share Capital and Earnings Per Share

The company maintained consistent equity structure with paid-up equity share capital of ₹1,463.48 lakh and face value of ₹10.00 per share. Basic earnings per share from continuing operations for Q3FY26 was ₹0.03, compared to ₹0.05 in the corresponding quarter of the previous year.

Accounting Standards and Segment Information

The financial results were prepared in accordance with Indian Accounting Standards 34 "Interim Financial Reporting" as prescribed under Section 133 of the Companies Act, 2013. The company operates in a single reportable segment as per Indian Accounting Standard 108 on "Operating Segment". The results were reviewed by the Audit Committee and subsequently approved by the Board of Directors, with statutory auditors conducting a limited review of the financial statements.